Vicarious Surgical Inc (RBOT): Enterprise Value to EBITDA Ratio
The EV/EBITDA multiples for Vicarious Surgical Inc. (RBOT) shown below stand at 0.00. The company develops advanced systems for minimally invasive interventions, targeting surgical clinics to reduce the cost of abdominal procedures. Its unique single-port method provides a technological edge and the potential for premium pricing power. Device assembly is carried out on modern production lines with superior technical equipment.
Comprehensive metric breakdowns and analytics for Vicarious Surgical Inc (RBOT)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Vicarious Surgical Inc.|RBOT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Vicarious Surgical Inc.|RBOT - Company Total Debt|Debts to Book Capitalization RBOT|RBOT - Long-Term Debt|Company Short-Term Debts Vicarious Surgical|Quick Ratio vicarioussurgical.com
- financial results and valuation multiples details:
RBOT - Net Financial Result|Projected Future Earnings Vicarious Surgical Inc.|RBOT - Price to Earnings Ratio|Forward P/E Multiple Vicarious Surgical Inc|RBOT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vicarious Surgical Inc.|RBOT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Vicarious Surgical|RBOT - Earnings per share for the trailing year|Quarterly EPS earnings growth vicarioussurgical.com|RBOT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Vicarious Surgical Inc.
- sales volume and revenue indicators:
Analysis of all company metrics:Vicarious Surgical Corp RBOT
The risk of asset undervaluation amid high debt loads is analyzed through the enterprise value to EBITDA ratio. For Vicarious Surgical Inc. (RBOT), which focuses on robot engineering and basic component utilization, the current EV/EBITDA multiple allows for a comparison between market capitalization, adjusted for debt, and the business's actual ability to generate cash flow.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple BDMD (Baird Medical Investment Holdings)|EV/EBITDA Multiple EDAP TMS S.A. EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (Pulmonx Corp.) - Enterprise Value to EBITDA Ratio|TELA Bio Inc. - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA Sensus Healthcare Inc SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex Medical (ZYXI)|electroCore Medical (ECOR) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
